A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Background: Depression and anxiety outcome measures, safety/tolerability, patient satisfaction, and ease of implementation of group-based ketamine-assisted psychotherapy (G-KAP) delivered to patients in intensive residential eating disorder (ED) treatment were assessed. Case presentation: This study reports on five participants with a diagnosis of an ED and comorbid mood and anxiety disorders who received weekly intramuscular ketamine injections in a group setting over 4 weeks. Measures of anxiety (GAD-7) and depression (PHQ-9) were administered pre-dose, 4-h post-dose, and 24-h post dose. Four of the 5 participants experienced clinically significant improvements on the PHQ-9 score (i.e., change greater than 5) while 2 of the 5 participants experienced clinically significant improvements on the GAD-7 score (i.e., change greater than 4) from pre-dose to 24-h post-dose after the last ketamine session. Dosing sessions were well tolerated, and no serious adverse events were reported. Clinical observations and participant reports corroborated improvements in depression and anxiety symptoms, good tolerability of ketamine treatment, and practical implementation of the G-KAP protocol in a residential ED treatment center. Conclusions: This study suggests the potential utility of G-KAP as an adjunct to intensive, specialized ED treatment. Overall, this novel, cross-diagnostic intervention warrants future research to further explore its appropriateness in a treatment setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“though there was no follow-up on ED symptoms [122]”
From Ketamine in neuropsychiatric disorders: an update (2024) · cites this paper as [122]
The cited source says what the claim attributes to it.
In the citing paper
“A case series (n = 5) found significant improvements in anxiety and depression measures after ketamine-assisted psychotherapy in a residential ED treatment center”
From Ketamine in neuropsychiatric disorders: an update (2024) · cites this paper as [122]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765 · cited 1×
“Generalized Anxiety Disorder Scale‐7 (GAD‐7) The GAD-7 is a 7-item questionnaire designed to measure symptoms of anxiety [34].”
BackgroundThe PHQ-9: A New Depression Diagnostic and Severity Measure
Kroenke, K., & Spitzer, R. L. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020901-06 · Cited by 5,898 · cited 1×
“Patient Health Questionnaire‐9 (PHQ‐9) The PHQ-9 is a 9-item questionnaire designed to measure the range and severity of symptoms of depression [32].”
BackgroundThe theory and practice of group psychotherapy.
Gullickson, T., & Ramser, P. (1996) · Contemporary Psychology: A Journal of Reviews · doi:10.1037/002652 · Cited by 1,894
Mechanisms of ketamine action as an antidepressant
Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127 · cited 4×
“The dissociative effects of ketamine appear to be dose-dependent and are commonly described as having an extracorporeal sensation that can be accompanied by synesthetic hallucinations, even when given at a subanesthetic doses [1, 9].”
BackgroundInfluentialTreasure, J., Claudino, A. M., & Zucker, N. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61748-7 · Cited by 658
Toussaint, A., Hüsing, P., Gumz, A., Wingenfeld, K., Härter, M., Schramm, E., & Löwe, B. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.032 · Cited by 641 · cited 1×
“The minimal clinically significant change on the GAD-7 was defined as a 4-point change [35].”
MethodA Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Sanacora, G., Frye, M. A., McDonald, W., Mathew, S. J., Turner, M. S., Schatzberg, A. F., Summergrad, P., Nemeroff, C. B., & for the American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0080 · Cited by 576 · cited 1×
“A conventional course of ketamine for sustained benefit typically requires multiple infusions at a high-frequency during an induction period, typically 6 sessions over 2–3 weeks, followed by lower-frequency treatment during maintenance treatment [11, 36].”
BackgroundPsychiatric Comorbidities of Female Inpatients With Eating Disorders
Blinder, B. J., Cumella, E. J., & Sanathara, V. A. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000221254.77675.f5 · Cited by 423
Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans
Clements, J. A., Nimmo, W. S., & Grant, I. S. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710516 · Cited by 420 · cited 1×
“dissociation and slight increases in blood pressure which have been observed to resolve upon elimination of ketamine from the system [1, 7, 8].”
BackgroundKhalsa, S. S., Portnoff, L. C., McCurdy-McKinnon, D., & Feusner, J. D. (2017) · Journal of Eating Disorders · doi:10.1186/s40337-017-0145-3 · Cited by 401 · cited 4×
“While the results among sufferers of EDs can be regarded as modest, they remain promising and point to the need for further research, in particular to treat psychiatric comorbidities.”
BackgroundInfluential
Research works printed but not linked: 1
- Bulik CM. Anxiety, depression and eating disorders. New York: Guilford Publications; 2002.
Cited by
Ketamine in neuropsychiatric disorders: an update
Johnston, J. N., Kadriu, B., Kraus, C., Henter, I. D., & Zarate, C. A. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-023-01632-1 · Cited by 108
“A case series ( n = 5) found signi fi cant improvements in anxiety and depression measures after ketamine-assisted psychotherapy in a residential ED treatment center, though there was no follow-up on ED symptoms [122].”
BackgroundMethodInfluentialKetamine and psychotherapy for the treatment of psychiatric disorders: Systematic review
Kew, B. M., Porter, R. J., Douglas, K. M., Glue, P., Mentzel, C. L., & Beaglehole, B. (2023) · BJPsych Open · doi:10.1192/bjo.2023.53 · Cited by 69
Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms
Calder, A. E., Mock, S., Friedli, N., Pasi, P., & Hasler, G. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.05.008 · Cited by 55
Established and emerging treatments for eating disorders
Bryson, C., Douglas, D., & Schmidt, U. H. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.02.009 · Cited by 41
Electrochemical and biosensor techniques to monitor neurotransmitter changes with depression
Dunham, K. E., & Venton, B. J. (2024) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-024-05136-9 · Cited by 33
“Likewise, depression is commonly diagnosed with other illnesses, such as anxiety and eating disorders [3].”
Background
Metadata
- Authors
- Robison, R., Lafrance, A., Brendle, M., Smith, M., Moore, C., Ahuja, S., Richards, S., Hawkins, N., & Strahan, E.
- Affiliations
- University of Utah (US)
- Wilfrid Laurier University (CA)
- Corresponding author
- Robison, Reid
- Venue
- Journal of Eating Disorders
- Published
- 2022-05-06
- Volume
- 10
- Issue
- 1
- Pages
- 65-65
- ISSN
- 2050-2974 (ISSN-L)
- PMC
- PMC9077943
- OpenAlex
- W4229078353
- Cited by
- 36
- References
- 37
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 9 · 2023: 9 · 2022: 1
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Eating Disorders (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- ketamine-assisted psychotherapy, group therapy, eating disorders, comorbid depression, anxiety disorders, residential treatment, intramuscular ketamine, adjunctive therapy, tolerability, treatment safety, patient satisfaction, mood and anxiety symptoms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders. https://app.cochat.ai/papers/10.1186/s40337-022-00588-9
- The paper
- Robison, R., Lafrance, A., Brendle, M., Smith, M., Moore, C., Ahuja, S., Richards, S., Hawkins, N., & Strahan, E. (2022). A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders. Journal of Eating Disorders. https://doi.org/10.1186/s40337-022-00588-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
